These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 24269566)
21. Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective study. Cesarini M; Katsanos K; Papamichael K; Ellul P; Lakatos PL; Caprioli F; Kopylov U; Tsianos E; Mantzaris GJ; Ben-Horin S; Danese S; Fiorino G Dig Liver Dis; 2014 Feb; 46(2):135-9. PubMed ID: 24246151 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus. Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441 [TBL] [Abstract][Full Text] [Related]
23. Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to? Gearry RB; Irving PM J Gastroenterol Hepatol; 2009 Jul; 24(7):1160-2. PubMed ID: 19682189 [No Abstract] [Full Text] [Related]
24. Etrolizumab for ulcerative colitis: the new kid on the block? Makker J; Hommes DW Expert Opin Biol Ther; 2016; 16(4):567-72. PubMed ID: 26914639 [TBL] [Abstract][Full Text] [Related]
33. Golimumab for moderately to severely active ulcerative colitis. Kedia S; Ahuja V; Makharia GK Expert Rev Clin Pharmacol; 2016 Oct; 9(10):1273-82. PubMed ID: 27498886 [TBL] [Abstract][Full Text] [Related]
34. Appendicectomy as a potential therapy for refractory ulcerative proctitis. Bageacu S; Coatmeur O; Lemaitre JP; Lointier P; Del Tedesco E; Phelip JM; Roblin X Aliment Pharmacol Ther; 2011 Jul; 34(2):257-8. PubMed ID: 21679209 [No Abstract] [Full Text] [Related]
35. Lower Dose Infliximab for Ulcerative Colitis: How Low Can We Go and How Much Can be Saved? Christophi GP; Ciorba MA J Clin Gastroenterol; 2015 Aug; 49(7):539-40. PubMed ID: 26057322 [No Abstract] [Full Text] [Related]
36. Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates. Halpin SJ; Hamlin PJ; Ford AC Aliment Pharmacol Ther; 2010 Nov; 32(10):1294-5. PubMed ID: 20955450 [No Abstract] [Full Text] [Related]
37. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Reinisch W; Sandborn WJ; Hommes DW; D'Haens G; Hanauer S; Schreiber S; Panaccione R; Fedorak RN; Tighe MB; Huang B; Kampman W; Lazar A; Thakkar R Gut; 2011 Jun; 60(6):780-7. PubMed ID: 21209123 [TBL] [Abstract][Full Text] [Related]
38. Infliximab rescue therapy in steroid-refractory ulcerative colitis: is more really more? Molnár T; Farkas K; Szepes Z; Nagy F; Wittmann T Aliment Pharmacol Ther; 2011 Feb; 33(3):412-3. PubMed ID: 21198699 [No Abstract] [Full Text] [Related]
39. Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis. van Asseldonk DP; Jharap B; Kuik DJ; de Boer NK; Westerveld BD; Russel MG; Kubben FJ; van Bodegraven AA; Mulder CJ Dig Liver Dis; 2011 Feb; 43(2):110-5. PubMed ID: 20739231 [TBL] [Abstract][Full Text] [Related]